Search

Results 1-10 of 169
Publication DateTitleAuthor(s)
25-Jul-2014Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancersFletcher, CE; Dart, DA; Bevan, CL
31-Jul-2015Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T, et al
10-Jan-2017CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolitesSood, D; Johnson, N; Jain, P; Siskos, AP; Bennett, M, et al
1-Jun-2015Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancerZhang, H; Angelopoulos, N; Xu, Y; Grothey, A; Nunes, J, et al
25-Oct-2014Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayAlshaker, H; Krell, J; Frampton, AE; Waxman, J; Blyuss, O, et al
12-Nov-2013SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1Zhang, H; Xu, Y; Filipovic, A; Lit, LC; Koo, C-Y, et al
17-Sep-2013'Being there' for women with metastatic breast cancer: a pan-European patient surveyHarding, V; Afshar, M; Krell, J; Ramaswami, R; Twelves, CJ, et al
30-Mar-2016ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradationNunes, J; Zhang, H; Angelopoulos, N; Chhetri, J; Osipo, C, et al
31-Jan-2016Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerFrench, JD; Johnatty, SE; Lu, Y; Beesley, J; Gao, B, et al
21-Aug-2015Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancerPalmieri, C; Macpherson, IRJ; Yan, K; Ades, F; Riddle, P, et al